Group One Trading
RIGL icon

Group One Trading’s Rigel Pharmaceuticals RIGL Stock Holding History

Group One Trading’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.7K Hold
100
– – ﹤0.01% 6954
2025
Q4 		$4.28K Sell
100
-8,500
-99% -$320K ﹤0.01% 7246
2025
Q3 		$244K Buy
8,600
+8,500
+8,500% +$254K ﹤0.01% 4465
2025
Q2 		$1.87K Buy
+100
New +$1.9K ﹤0.01% 7432
2024
Q4 		– Sell
-5,500
Closed -$89K – 7854
2024
Q3 		$89K Sell
5,500
-500
-8% -$5.88K ﹤0.01% 4274
2024
Q2 		$49.3K Buy
+6,000
New +$62.8K ﹤0.01% 4534
2024
Q1 		– Sell
-290
Closed -$4.21K – 7824
2023
Q4 		$4.21K Buy
290
+20
+7% +$205 ﹤0.01% 6576
2023
Q3 		$2.92K Sell
270
-220
-45% -$2.65K ﹤0.01% 6919
2023
Q2 		$6.32K Sell
490
-450
-48% -$6.08K ﹤0.01% 6612
2023
Q1 		$12.4K Buy
940
+450
+92% +$7.15K ﹤0.01% 5813
2022
Q4 		$7.35K Hold
490
– – ﹤0.01% 6163
2022
Q3 		$6K Sell
490
-470
-49% -$6.36K ﹤0.01% 6767
2022
Q2 		$11K Buy
960
+180
+23% +$3.62K ﹤0.01% 6714
2022
Q1 		$23K Sell
780
-690
-47% -$18.7K ﹤0.01% 6670
2021
Q4 		$39K Sell
1,470
-1,000
-40% -$30.2K ﹤0.01% 6519
2021
Q3 		$90K Sell
2,470
-40
-2% -$1.57K ﹤0.01% 6018
2021
Q2 		$109K Buy
2,510
+880
+54% +$33.2K ﹤0.01% 5858
2021
Q1 		$56K Sell
1,630
-7,040
-81% -$279K ﹤0.01% 6140
2020
Q4 		$303K Buy
8,670
+6,310
+267% +$183K ﹤0.01% 3727
2020
Q3 		$57K Buy
+2,360
New +$57.9K ﹤0.01% 4559
2020
Q1 		– Sell
-50
Closed -$1K – 5666
2019
Q4 		$1K Sell
50
-420
-89% -$8.65K ﹤0.01% 4985
2019
Q3 		$9K Hold
470
– – ﹤0.01% 4631
2019
Q2 		$12K Sell
470
-1,370
-74% -$30.9K ﹤0.01% 4362
2019
Q1 		$47K Buy
1,840
+560
+44% +$12.8K ﹤0.01% 3599
2018
Q4 		$29K Sell
1,280
-3,240
-72% -$91.4K ﹤0.01% 3837
2018
Q3 		$145K Buy
4,520
+400
+10% +$12K ﹤0.01% 3251
2018
Q2 		$117K Buy
4,120
+3,460
+524% +$123K ﹤0.01% 3448
2018
Q1 		$23K Buy
660
+310
+89% +$12.4K ﹤0.01% 4032
2017
Q4 		$14K Buy
+350
New +$13.3K ﹤0.01% 4283
2017
Q2 		– Sell
-200
Closed -$7K – 5029
2017
Q1 		$7K Sell
200
-300
-60% -$7.64K ﹤0.01% 4217
2016
Q4 		$12K Sell
500
-7,420
-94% -$213K ﹤0.01% 3897
2016
Q3 		$291K Buy
7,920
+7,160
+942% +$205K ﹤0.01% 2214
2016
Q2 		$17K Buy
+760
New +$18.9K ﹤0.01% 3869
2016
Q1 		– Sell
-100
Closed -$3K – 4880
2015
Q4 		$3K Sell
100
-570
-85% -$17.3K ﹤0.01% 4478
2015
Q3 		$17K Sell
670
-350
-34% -$10.4K ﹤0.01% 4112
2015
Q2 		$33K Buy
1,020
+800
+364% +$30.6K ﹤0.01% 3785
2015
Q1 		$8K Buy
+220
New +$6.03K ﹤0.01% 4230
2014
Q4 		– Sell
-100
Closed -$2K – 5215
2014
Q3 		$2K Sell
100
-400
-80% -$11.3K ﹤0.01% 4936
2014
Q2 		$18K Sell
500
-1,080
-68% -$36.7K ﹤0.01% 4233
2014
Q1 		$61K Buy
1,580
+660
+72% +$23.5K ﹤0.01% 3483
2013
Q4 		$26K Sell
920
-1,130
-55% -$33.2K ﹤0.01% 4100
2013
Q3 		$73K Buy
2,050
+80
+4% +$2.92K ﹤0.01% 3275
2013
Q2 		$66K Buy
+1,970
New +$89.3K ﹤0.01% 3188

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's RIGL Position: Q1 2026 in Review

Group One Trading sold out of Rigel Pharmaceuticals (RIGL) in Q1 2026, closing a stake of 638 shares — an estimated $21.4K sold.

Group One Trading first reported a position in RIGL in Q3 2013 and held it in 23 quarters. The position peaked at $448K in Q3 2021. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Group One Trading reported no remaining Rigel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 638 Rigel Pharmaceuticals shares in Q1 2026, an estimated $21.4K.
  • Group One Trading first reported a position in Rigel Pharmaceuticals in Q3 2013 and held it in 23 quarters.
  • Group One Trading's Rigel Pharmaceuticals position peaked at $448K in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.